Authors:
Alric, L
Duffaut, M
Selves, J
Sandre, K
Mularczyck, M
Izopet, J
Desmorat, H
Bureau, C
Chaouche, N
Dalbergue, B
Vinel, JP
Citation: L. Alric et al., Maintenance therapy with gradual reduction of the interferon dose over oneyear improves histological response in patients with chronic hepatitis C with biochemical response: results of a randomized trial, J HEPATOL, 35(2), 2001, pp. 272-278
Authors:
Theriault, C
Galoin, S
Valmary, S
Selves, J
Lamant, L
Roda, D
Rigal-Huguet, F
Brousset, P
Delsol, G
Al Saati, T
Citation: C. Theriault et al., PCR analysis of immunoglobulin heavy chain (IgH) and TcR-gamma chain gene rearrangements in the diagnosis of lymphoproliferative disorders: Results of a study of 525 cases, MOD PATHOL, 13(12), 2000, pp. 1269-1279
Authors:
Irsutti, M
Paul, JL
Selves, J
Railhac, JJ
Citation: M. Irsutti et al., Castleman disease: CT and MR imaging features of a retroperitoneal location in association with paraneoplastic pemphigus, EUR RADIOL, 9(6), 1999, pp. 1219-1221
Authors:
Guichard, S
Terret, C
Hennebelle, I
Lochon, I
Chevreau, P
Fretigny, E
Selves, J
Chatelut, E
Bugat, R
Canal, P
Citation: S. Guichard et al., CPT-11 converting carboxylesterase and topoisomerase I activities in tumour and normal colon and liver tissues, BR J CANC, 80(3-4), 1999, pp. 364-370
Authors:
Payen, JL
Izopet, J
Galindo-Migeot, V
Lauwers-Cances, V
Zarski, JP
Seigneurin, JM
Dussaix, E
Voigt, JJ
Selves, J
Barange, K
Puel, J
Pascal, JP
Citation: Jl. Payen et al., Better efficacy of a 12-month interferon alfa-2b retreatment in patients with chronic hepatitis C relapsing after a 6-month treatment: A multicenter,controlled, randomized trial, HEPATOLOGY, 28(6), 1998, pp. 1680-1686